NanoPass Technologies Ltd-医療機器分野:企業M&A・提携分析

◆英語タイトル:NanoPass Technologies Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011462
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NanoPass Technologies Ltd (NanoPass) is a medical device company that develops and markets intradermal delivery solutions for vaccines and drugs. The company offers product such as MicronJet600 needle, a single use microneedles based device for intradermal delivery. Its products are used with any standard syringe to inject drugs, proteins, and vaccines directly into the skin. NanoPass also develops hollow microneedles for solid microprojections and intradermal injections for cosmetic use. The company conducts clinical studies in North America, Europe, Israel, Hong Kong, Brazil, Bangladesh, and Japan. It supports multiple phase I-III clinical studies and partners with vaccine and immunotherapy product developers. NanoPass is headquartered in Nes Ziona, Israel.

NanoPass Technologies Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NanoPass Technologies Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
NanoPass Technologies Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
NanoPass Technologies Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
NanoPass Technologies Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
NanoPass Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
NanoPass Technologies Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
NanoPass Technologies Raises Funds Through Series B Financing 10
Partnerships 11
Circassia Pharma Enters into Licensing Agreement with NanoPass Technologies 11
NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 12
NanoPass Technologies Enters Into Licensing Agreement With Circassia 13
IDRI and NanoPass Tech Enter into Development Agreement 14
Acquisition 15
West Pharma Invests in NanoPass Technologies 15
NanoPass Technologies Ltd – Key Competitors 16
NanoPass Technologies Ltd – Key Employees 17
NanoPass Technologies Ltd – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
NanoPass Technologies Ltd, Medical Equipment, Key Facts 2
NanoPass Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
NanoPass Technologies Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
NanoPass Technologies Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
NanoPass Technologies Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
NanoPass Technologies Ltd, Deals By Market, 2011 to YTD 2017 8
NanoPass Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
NanoPass Technologies Raises Funds Through Series B Financing 10
Circassia Pharma Enters into Licensing Agreement with NanoPass Technologies 11
NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 12
NanoPass Technologies Enters Into Licensing Agreement With Circassia 13
IDRI and NanoPass Tech Enter into Development Agreement 14
West Pharma Invests in NanoPass Technologies 15
NanoPass Technologies Ltd, Key Competitors 16
NanoPass Technologies Ltd, Key Employees 17

★海外企業調査レポート[NanoPass Technologies Ltd-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medifast, Inc. (MED):企業の財務・戦略的SWOT分析
    Medifast, Inc. (MED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SM Energy Co Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    SM Energy Co Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary SM Energy Co (SM Energy) is an independent upstream oil and gas company. It carries out the acquisition, exploration, development, and production of crude oil, natural gas and natural gas liquids (NGLs) …
  • Feilo Sylvania Europe Ltd:企業の戦略的SWOT分析
    Feilo Sylvania Europe Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Credit Guarantee Insurance Corporation of Africa Ltd:企業の戦略・SWOT・財務分析
    Credit Guarantee Insurance Corporation of Africa Ltd - Strategy, SWOT and Corporate Finance Report Summary Credit Guarantee Insurance Corporation of Africa Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • Supernus Pharmaceuticals Inc (SUPN):企業の財務・戦略的SWOT分析
    Supernus Pharmaceuticals Inc (SUPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Tethys Oil AB (TETY):企業の財務・戦略的SWOT分析
    Summary Tethys Oil AB (Tethys Oil) is an upstream oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company holds onshore exploration licences in Lithuania and France. Tethys Oil holds Gargzdai license, Rietavas license and Raseiniai license …
  • Eddie Bauer LLC:企業の戦略的SWOT分析
    Eddie Bauer LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Palred Technologies Limited:戦略・SWOT・企業財務分析
    Palred Technologies Limited - Strategy, SWOT and Corporate Finance Report Summary Palred Technologies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Vivendi S.A.:戦略・SWOT・企業財務分析
    Vivendi S.A. - Strategy, SWOT and Corporate Finance Report Summary Vivendi S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Traverse Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Traverse Biosciences Inc (Traverse Biosciences) is an independent bioscience company that commercializes drug candidates for the treatment of inflammatory diseases and age-related conditions affecting humans and companion animals. The company’s lead candidate TRB-N0224 is developed for canin …
  • Valeant Canada LP-製薬・医療分野:企業M&A・提携分析
    Summary Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical company that manufactures, markets and distributes pharmaceutical products. The company offers its products in various therapeutic areas, including pain management, neurology, c …
  • BlueFire Renewables Inc (BFRE):企業の財務・戦略的SWOT分析
    Summary BlueFire Renewables Inc (BlueFire) is a producer and distributor of renewable liquid fuels. The company develops concentrated acid hydrolysis technology process for the profitable conversion of cellulosic waste materials such as green waste to ethanol, and other viable alternatives to petrol …
  • MallInckrodt Plc (MNK):医療機器:M&Aディール及び事業提携情報
    Summary Mallinckrodt Plc (Mallinckrodt) is develops, produces, commercializes, and distributes specialty pharmaceutical therapies and products. The company offers both branded and specialty generics for autoimmune and rare diseases in the specialty therapeutic areas of rheumatology, nephrology, neur …
  • CCA Industries, Inc.:企業の戦略・SWOT・財務情報
    CCA Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary CCA Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Zargon Oil & Gas Ltd (ZAR):石油・ガス:M&Aディール及び事業提携情報
    Summary Zargon Oil & Gas Ltd (Zargon) is an upstream energy company. It carries out the exploration, development and production of oil and natural gas. The company’s core business is oil exploitation in the Western Canadian and Williston sedimentary basins. The company also specializes in all three …
  • Synchrony Financial:企業の戦略・SWOT・財務分析
    Synchrony Financial - Strategy, SWOT and Corporate Finance Report Summary Synchrony Financial - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Swedbank AB:企業のM&A・事業提携・投資動向
    Swedbank AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swedbank AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • AeroControlex Group Inc.:企業の戦略・SWOT・財務情報
    AeroControlex Group Inc. - Strategy, SWOT and Corporate Finance Report Summary AeroControlex Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Engie Energia Chile SA (ECL):企業の財務・戦略的SWOT分析
    Engie Energia Chile SA (ECL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Tulip Star Hotels Limited:企業の戦略・SWOT・財務分析
    Tulip Star Hotels Limited - Strategy, SWOT and Corporate Finance Report Summary Tulip Star Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆